|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-7-21
|
|
pubmed:abstractText |
To investigate the anti-tumor activity of combined gemcitabine with dihydroartemisinin, and the mechanism of the anti-tumor effect of gemcitabine enhanced by dihydroartemisinin on pancreatic cancer.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0529-5815
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
530-4
|
|
pubmed:meshHeading |
pubmed-meshheading:20646665-Animals,
pubmed-meshheading:20646665-Antimetabolites, Antineoplastic,
pubmed-meshheading:20646665-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20646665-Apoptosis,
pubmed-meshheading:20646665-Artemisinins,
pubmed-meshheading:20646665-Cell Line, Tumor,
pubmed-meshheading:20646665-Deoxycytidine,
pubmed-meshheading:20646665-Humans,
pubmed-meshheading:20646665-Male,
pubmed-meshheading:20646665-Mice,
pubmed-meshheading:20646665-Mice, Nude,
pubmed-meshheading:20646665-NF-kappa B,
pubmed-meshheading:20646665-Pancreatic Neoplasms,
pubmed-meshheading:20646665-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
[Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].
|
|
pubmed:affiliation |
Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
